Check out our news section to keep up to date with any upcoming events which we will be attending as well as any exciting news within the pharmaceutical industry.
Leading on from the receipt of our Investigational Medicinal Products (IMP-MA) manufacturing licence from the UK Government regulator, the MHRA, in early 2012, Symbiosis hosted its first full MHRA cGMP inspection in December 2012.Not surprisingly, we are delighted to share with you that the inspection was successfully concluded to the satisfaction of the MHRA.This is another significant achievement for Symbiosis and is… Read More
“Our objective is to actively and aggressively drive down the amount of highly valuable drug development time”, Colin Mackay, Founder and CEORead the full story here :http://www.outsourcing-pharma.com/Contract-Manufacturing/Symbiosis-opens-contract-injectables-plant-for-early-phase
Symbiosis Pharmaceutical Services Limited, an MHRA-approved sterile manufacturing facility based in Stirling, Scotland is an exciting, young company specializing in the small-scale manufacture of sterile pharmaceuticals for clinical trials (fill/finish). Symbiosis has successfully completed clinical trial manufacturing projects with clients from across Europe and Asia, including Zealand Pharma A/S (NASDAQ OMX Copenhagen: ZEAL) and Encap Drug Delivery. The UK Government regulator, the… Read More